ATS: Untreated OSA Affects Outcomes After Revascularization

Share this content:
ATS: Untreated OSA Affects Outcomes After Revascularization
ATS: Untreated OSA Affects Outcomes After Revascularization

TUESDAY, May 17, 2016 (HealthDay News) -- Patients with obstructive sleep apnea (OSA) undergoing angioplasty may be at increased risk of a major adverse cardiac and cerebrovascular event (MACCE) after their procedure, according to findings presented at the annual meeting of the American Thoracic Society, held from May 13 to 18 in San Francisco.

Researchers tracked 1,311 patients from Brazil, China, India, Myanmar, and Singapore who had undergone angioplasty with stents. Almost 60 percent of the patients were overweight or obese, and 45.3 percent were diagnosed with OSA. The patients were followed for a median of two years. Just 1.3 percent of those diagnosed with OSA were being treated via continuous positive airway pressure, by the end of the study.

The researchers found that patients with OSA had 1.57 times the risk of other patients of incurring a MACCE. The findings held after adjustment for age, sex, ethnicity, body mass index, diabetes, and hypertension.

"For cardiologists inserting stents for coronary artery disease, it is important to screen the patients for OSA," study author Lee Chi-Hang, M.B.B.S., M.D., a senior consultant in the department of cardiology at the National University of Singapore Heart Center, told HealthDay. "And patients who have been diagnosed with sleep apnea should know about the strong relationship between sleep apnea and heart disease."

Press Release
More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths